DaVita Inc. (NYSE:DVA) Holdings Raised by National Bank of Canada FI

National Bank of Canada FI raised its stake in DaVita Inc. (NYSE:DVA - Free Report) by 14.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 38,232 shares of the company's stock after purchasing an additional 4,876 shares during the period. National Bank of Canada FI's holdings in DaVita were worth $6,267,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. ORG Partners LLC acquired a new stake in shares of DaVita during the second quarter worth $82,000. Assenagon Asset Management S.A. lifted its holdings in DaVita by 29.6% in the second quarter. Assenagon Asset Management S.A. now owns 50,096 shares of the company's stock valued at $6,942,000 after acquiring an additional 11,454 shares during the period. Blue Trust Inc. lifted its holdings in DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock valued at $29,000 after acquiring an additional 78 shares during the period. Chapin Davis Inc. acquired a new position in shares of DaVita during the 2nd quarter worth $2,228,000. Finally, Nisa Investment Advisors LLC raised its stake in shares of DaVita by 26.8% during the 2nd quarter. Nisa Investment Advisors LLC now owns 36,694 shares of the company's stock worth $5,085,000 after buying an additional 7,752 shares during the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Javier Rodriguez sold 50,000 shares of the business's stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the transaction, the chief executive officer now directly owns 837,835 shares of the company's stock, valued at approximately $138,284,666.75. The trade was a 5.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on DVA shares. Barclays lifted their price target on DaVita from $150.00 to $164.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 31st. Truist Financial lifted their price target on DaVita from $165.00 to $175.00 and gave the stock a "hold" rating in a research note on Monday, October 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $161.80.

DaVita Trading Down 0.8 %

Shares of NYSE:DVA traded down $1.17 during trading on Friday, reaching $152.73. 508,605 shares of the stock were exchanged, compared to its average volume of 809,431. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita Inc. has a 12-month low of $103.40 and a 12-month high of $169.51. The firm has a market cap of $12.52 billion, a price-to-earnings ratio of 16.48, a price-to-earnings-growth ratio of 0.88 and a beta of 0.90. The firm's 50-day moving average price is $158.10 and its 200 day moving average price is $150.68.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion for the quarter, compared to analysts' expectations of $3.25 billion. During the same quarter in the previous year, the firm posted $2.85 EPS. The firm's revenue for the quarter was up 4.6% compared to the same quarter last year. On average, sell-side analysts anticipate that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.